Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

861
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
861

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Nature cancer·2026
Same author

Between awe and despair: recognising risk in veterinary suicide.

The Veterinary record·2026
Same author

A gene-editing method generates immunotherapeutic CAR T cells in the body.

Nature·2026
Same author

Identification of novel DNA sequence motifs that modulate transcription in T cells.

BMC genomics·2026
Same author

Facilitating family centred care: the co-design development of text messages for fathers with an infant in NICU.

Informatics for health & social care·2025
Same author

Effectiveness of Father-Focused Interventions to Prevent or Reduce Intimate Partner Violence During Pregnancy and Early Parenthood: A Systematic Review.

Trauma, violence & abuse·2024

Related Experiment Video

Updated: Jun 16, 2025

Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs
11:21

Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs

Published on: September 10, 2017

9.4K

A synthetic cytotoxic T cell platform for rapidly prototyping TCR function.

Govinda Sharma1, James Round1, Fei Teng1

  • 1Michael Smith Genome Sciences Centre, British Columbia Cancer Research Institute, Vancouver, BC, Canada.

NPJ Precision Oncology
|August 19, 2024
PubMed
Summary

Researchers developed a new bioplatform for T cell receptor (TCR) profiling. This system enables rapid assessment of TCR cytotoxic potency and antigen recognition, overcoming limitations of current methods.

More Related Videos

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
08:48

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Published on: October 25, 2016

8.5K
Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice
09:08

Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice

Published on: July 11, 2016

9.6K

Related Experiment Videos

Last Updated: Jun 16, 2025

Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs
11:21

Streamlined Single Cell TCR Isolation and Generation of Retroviral Vectors for In Vitro and In Vivo Expression of Human TCRs

Published on: September 10, 2017

9.4K
Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain
08:48

Generating De Novo Antigen-specific Human T Cell Receptors by Retroviral Transduction of Centric Hemichain

Published on: October 25, 2016

8.5K
Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice
09:08

Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice

Published on: July 11, 2016

9.6K

Area of Science:

  • Immunology
  • Cell Biology
  • Biotechnology

Background:

  • Current methods for profiling T cell receptor (TCR) function, including cytotoxic potency and cross-reactivity, face challenges in establishing model systems for diverse HLA alleles and antigens.
  • Testing TCRs requires complex systems that can accommodate various HLA types and a wide range of potential antigens.

Purpose of the Study:

  • To develop a universal prototyping platform for functional profiling of T cell receptors (TCRs) with enhanced cytotoxic potency and cross-reactivity assessment.
  • To create a system enabling facile recombinant expression of TCR, peptide, and MHC-I coding sequences for direct response assessment.

Main Methods:

  • Implementation of a granzyme-activatable sensor for T cell cytotoxicity.
  • Engineering of an immortalized natural killer cell line (YT-Indy) and an MHC-null antigen-presenting cell line (K562) into a universal prototyping platform.
  • Integration of a fluorescence-based reporter for early detection of cytotoxic function and genetic interventions to preserve target cells.

Main Results:

  • Successful reconstitution of the surface TCR complex in the YT-Indy cell line at biologically relevant levels.
  • Demonstrated successful induction and highly sensitive detection of antigen-specific responses for multiple distinct model TCRs.
  • Confirmed preservation of target cells after 24-hour exposure to cytotoxic effectors in co-culture experiments.

Conclusions:

  • The developed bioplatform facilitates rapid expression and characterization of T cell receptor (TCR) responses.
  • This system empowers researchers to gain insights into TCR recognition patterns and optimize therapeutic TCRs.
  • The platform overcomes previous limitations in testing TCRs against diverse HLA alleles and antigens, advancing TCR-based research and therapeutics.